Corporate

Biomarkers in Clinical Development Track

Tuesday May 20th Technology Spotlight: Theranostics Health
Title: Reverse-phase protein microarrays: identification and quantitation of signaling pathway biomarkers in cell lines, tumors and patient populations for drug discovery, clinical trials and companion diagnostics

Laris, Michael. "In a Va. Lab, Forging Links to Speed Cancer
Advances: GMU, With Ties to Italy, Aims to Be a Biotech Force" Washington Post,
February 27, 2008; Page B01

Click to view Article